PPSI petitions FDA to increase print size in DTC ads
Pharmacists Planning Service Inc. (PPSI), a nonprofit organization that promotes consumer public health education, has sent a petition to the FDA requesting the agency immediately increase the print size of direct-to-consumer (DTC) ads. In its petition, PPSI stated, "These ads basically are for prescription drugs." PPSI sent a series of ads from various magazines to FDA urging the following, "Please note the difficulty patients and consumers have in reading them, especially seniors, who are only 13% of the population, but who use 43% of all prescription drugs, OTC drugs, and herbals." PPSI is requesting that FTC and FDA institute uniformity and guidelines for the readability for DTC ads.
To see more Hot off the Press news articles, click here.
To go to the Drug Topics homepage, click here.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
